Gene Symbol | Gene ID | Gene Info |
---|---|---|
Max
|
ENSMUSG00000059436.6 | Max protein |
Mycn
|
ENSMUSG00000037169.8 | v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_76962549_76962980 | Max | 563 | 0.727560 | 0.63 | 5.8e-08 | Click! |
chr12_76961051_76962115 | Max | 338 | 0.863858 | 0.42 | 8.0e-04 | Click! |
chr12_76963035_76963186 | Max | 909 | 0.541518 | 0.34 | 7.9e-03 | Click! |
chr12_76957360_76958098 | Max | 3320 | 0.207680 | -0.23 | 7.1e-02 | Click! |
chr12_76959326_76959482 | Max | 2517 | 0.241948 | -0.23 | 7.2e-02 | Click! |
chr12_12942475_12942956 | Mycn | 801 | 0.531186 | 0.49 | 6.9e-05 | Click! |
chr12_12941505_12941775 | Mycn | 185 | 0.921231 | 0.45 | 3.3e-04 | Click! |
chr12_12941909_12942444 | Mycn | 262 | 0.880044 | 0.41 | 1.1e-03 | Click! |
chr12_12939480_12941443 | Mycn | 155 | 0.934226 | 0.37 | 3.7e-03 | Click! |
chr12_12937101_12937478 | Mycn | 3327 | 0.168614 | 0.36 | 4.5e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_142367506_142367696 | 3.12 |
Foxk1 |
forkhead box K1 |
33896 |
0.18 |
chr1_74090075_74091356 | 2.90 |
Tns1 |
tensin 1 |
636 |
0.71 |
chr8_119604190_119605195 | 2.88 |
Taf1c |
TATA-box binding protein associated factor, RNA polymerase I, C |
514 |
0.63 |
chr6_124964842_124965474 | 2.75 |
Cops7a |
COP9 signalosome subunit 7A |
49 |
0.91 |
chr14_28508297_28508556 | 2.56 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
2192 |
0.3 |
chr12_84175369_84176722 | 2.50 |
Gm19327 |
predicted gene, 19327 |
11761 |
0.1 |
chr11_6527849_6528713 | 2.49 |
Snora9 |
small nucleolar RNA, H/ACA box 9 |
116 |
0.81 |
chr4_148591515_148592619 | 2.47 |
Srm |
spermidine synthase |
149 |
0.91 |
chr7_105777795_105779093 | 2.47 |
Dchs1 |
dachsous cadherin related 1 |
9108 |
0.09 |
chr4_155409208_155409931 | 2.39 |
Cfap74 |
cilia and flagella associated protein 74 |
311 |
0.83 |
chr4_156236727_156237032 | 2.38 |
Noc2l |
NOC2 like nucleolar associated transcriptional repressor |
340 |
0.74 |
chr19_10940219_10941485 | 2.29 |
Ptgdr2 |
prostaglandin D2 receptor 2 |
3692 |
0.13 |
chr15_81802115_81803592 | 2.28 |
Tef |
thyrotroph embryonic factor |
27 |
0.75 |
chr7_105786634_105787065 | 2.25 |
Dchs1 |
dachsous cadherin related 1 |
703 |
0.51 |
chr5_140389256_140389668 | 2.24 |
Snx8 |
sorting nexin 8 |
200 |
0.91 |
chr6_51591921_51593175 | 2.22 |
Gm22914 |
predicted gene, 22914 |
29084 |
0.18 |
chr5_136170674_136171277 | 2.16 |
Orai2 |
ORAI calcium release-activated calcium modulator 2 |
262 |
0.85 |
chr8_119911180_119911715 | 2.14 |
Usp10 |
ubiquitin specific peptidase 10 |
590 |
0.44 |
chr6_145187575_145187803 | 2.14 |
Gm15543 |
predicted gene 15543 |
5414 |
0.12 |
chr2_160645540_160645748 | 2.13 |
Top1 |
topoisomerase (DNA) I |
244 |
0.92 |
chr10_121626587_121626912 | 2.12 |
Xpot |
exportin, tRNA (nuclear export receptor for tRNAs) |
417 |
0.79 |
chr5_111419755_111420664 | 2.12 |
Mn1 |
meningioma 1 |
2767 |
0.22 |
chr3_49753928_49755610 | 2.11 |
Pcdh18 |
protocadherin 18 |
695 |
0.72 |
chr5_121828742_121829564 | 2.09 |
Sh2b3 |
SH2B adaptor protein 3 |
412 |
0.73 |
chr4_154639076_154640482 | 2.04 |
Prdm16os |
Prdm16 opposite strand transcript |
2203 |
0.2 |
chr17_32165675_32166119 | 2.03 |
Notch3 |
notch 3 |
955 |
0.45 |
chr5_104046345_104046782 | 2.01 |
Nudt9 |
nudix (nucleoside diphosphate linked moiety X)-type motif 9 |
37 |
0.92 |
chr6_126134559_126134999 | 2.01 |
Ntf3 |
neurotrophin 3 |
30181 |
0.23 |
chr9_107587725_107589000 | 2.00 |
Ifrd2 |
interferon-related developmental regulator 2 |
605 |
0.33 |
chr12_79191005_79191867 | 1.98 |
Rdh11 |
retinol dehydrogenase 11 |
357 |
0.78 |
chr3_88177228_88177778 | 1.95 |
1700113A16Rik |
RIKEN cDNA 1700113A16 gene |
189 |
0.88 |
chr13_49319308_49320561 | 1.95 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
377 |
0.86 |
chr5_74194924_74195157 | 1.94 |
Rasl11b |
RAS-like, family 11, member B |
246 |
0.9 |
chr5_110386046_110387130 | 1.92 |
Fbrsl1 |
fibrosin-like 1 |
374 |
0.79 |
chr10_63024062_63024799 | 1.91 |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
82 |
0.67 |
chr6_6878154_6880927 | 1.89 |
Dlx5 |
distal-less homeobox 5 |
2528 |
0.19 |
chr6_125081185_125081908 | 1.88 |
2010008C14Rik |
RIKEN cDNA 2010008C14 gene |
1891 |
0.14 |
chr15_86058342_86058650 | 1.88 |
Gramd4 |
GRAM domain containing 4 |
231 |
0.93 |
chr13_21171607_21172290 | 1.87 |
Trim27 |
tripartite motif-containing 27 |
7497 |
0.14 |
chr9_58489768_58490364 | 1.84 |
Insyn1 |
inhibitory synaptic factor 1 |
458 |
0.81 |
chr11_119252172_119253115 | 1.83 |
Ccdc40 |
coiled-coil domain containing 40 |
910 |
0.45 |
chr8_11187747_11188818 | 1.83 |
Gm15418 |
predicted gene 15418 |
527 |
0.75 |
chr18_67464588_67465490 | 1.82 |
Prelid3a |
PRELI domain containing 3A |
148 |
0.94 |
chr18_66291045_66291813 | 1.81 |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
17 |
0.66 |
chr9_44066671_44066925 | 1.81 |
Usp2 |
ubiquitin specific peptidase 2 |
223 |
0.83 |
chr11_73019049_73019813 | 1.78 |
Camkk1 |
calcium/calmodulin-dependent protein kinase kinase 1, alpha |
388 |
0.57 |
chr14_72531887_72532977 | 1.78 |
Mlnr-ps |
motilin receptor, pseudogene |
217 |
0.94 |
chr11_72215270_72215726 | 1.77 |
Med31 |
mediator complex subunit 31 |
94 |
0.77 |
chr3_131113119_131113270 | 1.77 |
Lef1 |
lymphoid enhancer binding factor 1 |
388 |
0.75 |
chr8_94214245_94214429 | 1.76 |
Nup93 |
nucleoporin 93 |
227 |
0.88 |
chr9_21165088_21165669 | 1.75 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
336 |
0.78 |
chr11_60811083_60811590 | 1.74 |
Shmt1 |
serine hydroxymethyltransferase 1 (soluble) |
71 |
0.93 |
chr5_76950389_76951159 | 1.74 |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
391 |
0.55 |
chr11_100639930_100640993 | 1.73 |
Gm44544 |
predicted gene 44544 |
2656 |
0.14 |
chr15_102279100_102279328 | 1.72 |
Mfsd5 |
major facilitator superfamily domain containing 5 |
240 |
0.83 |
chr11_100939782_100940185 | 1.72 |
Stat3 |
signal transducer and activator of transcription 3 |
443 |
0.77 |
chr2_130273870_130274208 | 1.70 |
Nop56 |
NOP56 ribonucleoprotein |
391 |
0.63 |
chr7_99468579_99468981 | 1.70 |
Klhl35 |
kelch-like 35 |
183 |
0.9 |
chr1_18057820_18058958 | 1.69 |
Gm45784 |
predicted gene 45784 |
120 |
0.8 |
chr15_79030902_79031405 | 1.69 |
Gcat |
glycine C-acetyltransferase (2-amino-3-ketobutyrate-coenzyme A ligase) |
252 |
0.77 |
chr18_80295599_80296556 | 1.68 |
Gm37015 |
predicted gene, 37015 |
7603 |
0.13 |
chr2_32961788_32962912 | 1.68 |
Rpl12 |
ribosomal protein L12 |
84 |
0.88 |
chr17_25699963_25700114 | 1.68 |
Gm50312 |
predicted gene, 50312 |
1184 |
0.18 |
chr6_29388244_29389129 | 1.68 |
Opn1sw |
opsin 1 (cone pigments), short-wave-sensitive (color blindness, tritan) |
218 |
0.87 |
chr4_57567646_57569018 | 1.67 |
Pakap |
paralemmin A kinase anchor protein |
2 |
0.99 |
chr8_84872535_84872987 | 1.67 |
Syce2 |
synaptonemal complex central element protein 2 |
323 |
0.71 |
chr3_88532737_88533937 | 1.66 |
Mex3a |
mex3 RNA binding family member A |
942 |
0.3 |
chr6_148945311_148945462 | 1.66 |
3010003L21Rik |
RIKEN cDNA 3010003L21 gene |
519 |
0.43 |
chr9_78527234_78527865 | 1.66 |
Gm47430 |
predicted gene, 47430 |
7003 |
0.14 |
chr4_108579452_108580090 | 1.65 |
Orc1 |
origin recognition complex, subunit 1 |
317 |
0.55 |
chr2_130274499_130275196 | 1.64 |
Nop56 |
NOP56 ribonucleoprotein |
16 |
0.89 |
chr10_125967796_125968797 | 1.63 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2043 |
0.45 |
chr7_43444150_43444651 | 1.60 |
Etfb |
electron transferring flavoprotein, beta polypeptide |
250 |
0.46 |
chr16_74070800_74070951 | 1.58 |
Gm49660 |
predicted gene, 49660 |
5022 |
0.22 |
chr1_138876073_138877030 | 1.58 |
1700019P21Rik |
RIKEN cDNA 1700019P21 gene |
400 |
0.75 |
chr4_127077094_127077308 | 1.57 |
Zmym6 |
zinc finger, MYM-type 6 |
182 |
0.9 |
chr2_168280348_168281167 | 1.56 |
Kcng1 |
potassium voltage-gated channel, subfamily G, member 1 |
375 |
0.8 |
chr19_23140808_23141190 | 1.55 |
Klf9 |
Kruppel-like factor 9 |
227 |
0.92 |
chr14_122202569_122202874 | 1.54 |
Clybl |
citrate lyase beta like |
21017 |
0.16 |
chr13_22034575_22035571 | 1.54 |
Gm44390 |
predicted gene, 44390 |
91 |
0.77 |
chr8_105936769_105936997 | 1.54 |
Psmb10 |
proteasome (prosome, macropain) subunit, beta type 10 |
142 |
0.87 |
chr7_78989959_78991095 | 1.54 |
Gm26633 |
predicted gene, 26633 |
62796 |
0.08 |
chr2_32693250_32694110 | 1.52 |
Fpgs |
folylpolyglutamyl synthetase |
436 |
0.6 |
chr11_86807701_86808083 | 1.52 |
Dhx40 |
DEAH (Asp-Glu-Ala-His) box polypeptide 40 |
146 |
0.97 |
chr10_82623274_82623536 | 1.52 |
1190007I07Rik |
RIKEN cDNA 1190007I07 gene |
177 |
0.93 |
chr15_85831834_85832231 | 1.52 |
Ttc38 |
tetratricopeptide repeat domain 38 |
274 |
0.86 |
chr17_49615148_49615866 | 1.51 |
Kif6 |
kinesin family member 6 |
335 |
0.92 |
chr11_77491386_77492100 | 1.51 |
Git1 |
GIT ArfGAP 1 |
1819 |
0.2 |
chr10_81643775_81643995 | 1.50 |
Ankrd24 |
ankyrin repeat domain 24 |
82 |
0.93 |
chr6_131387291_131387817 | 1.50 |
Ybx3 |
Y box protein 3 |
884 |
0.51 |
chr10_128564820_128565941 | 1.50 |
Pa2g4 |
proliferation-associated 2G4 |
489 |
0.54 |
chr11_7213307_7213604 | 1.50 |
Igfbp3 |
insulin-like growth factor binding protein 3 |
442 |
0.82 |
chr12_104471272_104472544 | 1.49 |
Gsc |
goosecoid homeobox |
1422 |
0.28 |
chr7_128462014_128462350 | 1.49 |
Gm32816 |
predicted gene, 32816 |
114 |
0.82 |
chr8_124663509_124663660 | 1.49 |
2310022B05Rik |
RIKEN cDNA 2310022B05 gene |
215 |
0.92 |
chr11_108925496_108926003 | 1.49 |
Axin2 |
axin 2 |
2568 |
0.3 |
chr13_47014022_47014840 | 1.49 |
Nhlrc1 |
NHL repeat containing 1 |
419 |
0.7 |
chr7_29341684_29341920 | 1.48 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
66 |
0.96 |
chr18_35889061_35889377 | 1.48 |
Gm36315 |
predicted gene, 36315 |
1118 |
0.34 |
chr11_58167699_58168475 | 1.48 |
Gemin5 |
gem nuclear organelle associated protein 5 |
452 |
0.69 |
chr7_130260560_130262022 | 1.48 |
Fgfr2 |
fibroblast growth factor receptor 2 |
566 |
0.84 |
chr4_133910280_133910686 | 1.48 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
22686 |
0.11 |
chr9_66713424_66714614 | 1.48 |
Car12 |
carbonic anhydrase 12 |
289 |
0.91 |
chr11_79254808_79254959 | 1.47 |
Wsb1 |
WD repeat and SOCS box-containing 1 |
212 |
0.93 |
chr4_155770405_155770829 | 1.47 |
Vwa1 |
von Willebrand factor A domain containing 1 |
4081 |
0.08 |
chr7_12779708_12780665 | 1.47 |
Zscan18 |
zinc finger and SCAN domain containing 18 |
468 |
0.47 |
chr14_69554959_69555320 | 1.47 |
Gm27174 |
predicted gene 27174 |
193 |
0.59 |
chr8_66861077_66861478 | 1.46 |
Naf1 |
nuclear assembly factor 1 ribonucleoprotein |
320 |
0.89 |
chr13_51418252_51418766 | 1.46 |
Gm32834 |
predicted gene, 32834 |
136 |
0.96 |
chr15_100914634_100914945 | 1.46 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
18640 |
0.18 |
chr7_19523621_19524689 | 1.46 |
Nkpd1 |
NTPase, KAP family P-loop domain containing 1 |
5424 |
0.09 |
chr8_122268804_122269610 | 1.46 |
Zfp469 |
zinc finger protein 469 |
362 |
0.85 |
chr15_73724434_73724829 | 1.45 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
167 |
0.94 |
chr8_72443233_72443710 | 1.45 |
Calr3 |
calreticulin 3 |
399 |
0.43 |
chr6_91212520_91213912 | 1.45 |
Fbln2 |
fibulin 2 |
385 |
0.81 |
chr9_78520767_78521576 | 1.45 |
Gm47430 |
predicted gene, 47430 |
625 |
0.63 |
chr3_87906019_87906170 | 1.45 |
Hdgf |
heparin binding growth factor |
227 |
0.86 |
chr14_69336710_69337073 | 1.45 |
Gm16677 |
predicted gene, 16677 |
191 |
0.59 |
chr8_36094859_36095797 | 1.44 |
Prag1 |
PEAK1 related kinase activating pseudokinase 1 |
467 |
0.82 |
chr7_142572609_142572925 | 1.44 |
H19 |
H19, imprinted maternally expressed transcript |
3771 |
0.12 |
chr11_69368080_69368927 | 1.44 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
888 |
0.34 |
chr7_16892200_16892882 | 1.44 |
Gng8 |
guanine nucleotide binding protein (G protein), gamma 8 |
220 |
0.83 |
chr9_21204379_21205155 | 1.44 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
8062 |
0.1 |
chr2_103760526_103761214 | 1.43 |
Nat10 |
N-acetyltransferase 10 |
56 |
0.96 |
chr9_72437990_72438409 | 1.43 |
Mns1 |
meiosis-specific nuclear structural protein 1 |
188 |
0.86 |
chr14_115042295_115042643 | 1.43 |
Mir17hg |
Mir17 host gene (non-protein coding) |
410 |
0.54 |
chr1_161036528_161036701 | 1.43 |
Gm23212 |
predicted gene, 23212 |
68 |
0.41 |
chr17_25569996_25570672 | 1.42 |
Cerox1 |
cytoplasmic endogenous regulator of oxidative phosphorylation 1 |
24 |
0.6 |
chr10_77033198_77034026 | 1.42 |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
293 |
0.85 |
chr10_103367864_103369217 | 1.42 |
Slc6a15 |
solute carrier family 6 (neurotransmitter transporter), member 15 |
697 |
0.75 |
chr8_33833218_33834143 | 1.42 |
Rbpms |
RNA binding protein gene with multiple splicing |
9991 |
0.16 |
chr11_102605789_102606436 | 1.42 |
Fzd2 |
frizzled class receptor 2 |
1716 |
0.21 |
chr5_112153542_112154115 | 1.41 |
1700016B01Rik |
RIKEN cDNA 1700016B01 gene |
2409 |
0.28 |
chr4_117120700_117121383 | 1.41 |
Btbd19 |
BTB (POZ) domain containing 19 |
224 |
0.81 |
chr1_161035237_161036498 | 1.41 |
Gm22489 |
predicted gene, 22489 |
17 |
0.46 |
chr6_144202688_144204608 | 1.40 |
Sox5 |
SRY (sex determining region Y)-box 5 |
409 |
0.92 |
chr15_98727036_98728170 | 1.40 |
Fkbp11 |
FK506 binding protein 11 |
537 |
0.61 |
chr9_65390681_65391939 | 1.40 |
Kbtbd13 |
kelch repeat and BTB (POZ) domain containing 13 |
342 |
0.76 |
chr19_57360245_57360728 | 1.40 |
Fam160b1 |
family with sequence similarity 160, member B1 |
194 |
0.57 |
chr8_83667762_83669070 | 1.39 |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
1274 |
0.29 |
chr2_11501504_11502110 | 1.39 |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
10 |
0.97 |
chr4_63214008_63214950 | 1.39 |
Col27a1 |
collagen, type XXVII, alpha 1 |
475 |
0.8 |
chr9_53610375_53610679 | 1.39 |
Acat1 |
acetyl-Coenzyme A acetyltransferase 1 |
145 |
0.94 |
chr10_75859024_75859840 | 1.39 |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
760 |
0.45 |
chr10_105570956_105571380 | 1.39 |
Gm15663 |
predicted gene 15663 |
2785 |
0.21 |
chr4_74013098_74014374 | 1.38 |
Frmd3 |
FERM domain containing 3 |
292 |
0.91 |
chr8_122335750_122336915 | 1.38 |
Zfpm1 |
zinc finger protein, multitype 1 |
1701 |
0.24 |
chr16_90144320_90144513 | 1.38 |
Tiam1 |
T cell lymphoma invasion and metastasis 1 |
647 |
0.7 |
chr17_56276798_56277111 | 1.38 |
Ticam1 |
toll-like receptor adaptor molecule 1 |
168 |
0.89 |
chr3_95905050_95905917 | 1.37 |
Car14 |
carbonic anhydrase 14 |
792 |
0.39 |
chr6_145855324_145856436 | 1.37 |
Gm43909 |
predicted gene, 43909 |
7417 |
0.17 |
chr15_96543520_96543906 | 1.37 |
Slc38a1 |
solute carrier family 38, member 1 |
35871 |
0.16 |
chr12_72760498_72761039 | 1.37 |
Ppm1a |
protein phosphatase 1A, magnesium dependent, alpha isoform |
27 |
0.98 |
chr7_29001253_29001878 | 1.37 |
Map4k1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
23 |
0.96 |
chr8_122230916_122231166 | 1.36 |
Zfp469 |
zinc finger protein 469 |
27579 |
0.16 |
chr1_42684511_42685482 | 1.36 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
8097 |
0.14 |
chr2_156839408_156839722 | 1.36 |
Gm14230 |
predicted gene 14230 |
235 |
0.65 |
chr4_82499658_82501360 | 1.36 |
Nfib |
nuclear factor I/B |
1193 |
0.5 |
chr9_42520498_42521281 | 1.35 |
Tbcel |
tubulin folding cofactor E-like |
13080 |
0.22 |
chr11_87442706_87442946 | 1.35 |
Rnu3b1 |
U3B small nuclear RNA 1 |
411 |
0.65 |
chrX_104482810_104483864 | 1.35 |
Uprt |
uracil phosphoribosyltransferase |
519 |
0.84 |
chr8_60983455_60983912 | 1.35 |
B230317F23Rik |
RIKEN cDNA B230317F23 gene |
246 |
0.63 |
chr5_135250087_135251185 | 1.35 |
Fzd9 |
frizzled class receptor 9 |
594 |
0.63 |
chr16_78376946_78377337 | 1.35 |
Btg3 |
BTG anti-proliferation factor 3 |
51 |
0.97 |
chr1_87475065_87476008 | 1.35 |
Snorc |
secondary ossification center associated regulator of chondrocyte maturation |
2997 |
0.17 |
chr11_69065926_69067384 | 1.35 |
Tmem107 |
transmembrane protein 107 |
4151 |
0.08 |
chr11_98927805_98928959 | 1.34 |
Rara |
retinoic acid receptor, alpha |
564 |
0.62 |
chr2_167777077_167778323 | 1.34 |
Gm14321 |
predicted gene 14321 |
164 |
0.94 |
chr4_41740293_41741309 | 1.34 |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
247 |
0.83 |
chr19_5730855_5731664 | 1.34 |
Znrd2 |
zinc ribbon domain containing 2 |
216 |
0.64 |
chr2_121168032_121168219 | 1.34 |
Zscan29 |
zinc finger SCAN domains 29 |
2143 |
0.17 |
chr9_14174943_14175740 | 1.33 |
Gm47564 |
predicted gene, 47564 |
28742 |
0.15 |
chr12_27338723_27339386 | 1.33 |
Sox11 |
SRY (sex determining region Y)-box 11 |
3520 |
0.35 |
chr7_67803192_67804449 | 1.33 |
4833412C05Rik |
RIKEN cDNA 4833412C05 gene |
319 |
0.83 |
chr16_17124045_17125141 | 1.33 |
Mir301b |
microRNA 301b |
97 |
0.74 |
chr11_54067330_54067714 | 1.33 |
Pdlim4 |
PDZ and LIM domain 4 |
1410 |
0.37 |
chr2_167064703_167065302 | 1.33 |
Gm23201 |
predicted gene, 23201 |
4 |
0.77 |
chr5_138255119_138255558 | 1.32 |
Lamtor4 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 |
144 |
0.87 |
chr1_72824099_72824390 | 1.32 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
259 |
0.93 |
chr3_96497240_96498087 | 1.31 |
Gm22614 |
predicted gene, 22614 |
8934 |
0.07 |
chr6_83316808_83317533 | 1.31 |
Gm43890 |
predicted gene, 43890 |
227 |
0.64 |
chr5_92137312_92137746 | 1.30 |
Uso1 |
USO1 vesicle docking factor |
409 |
0.75 |
chr15_79327226_79328180 | 1.30 |
Pla2g6 |
phospholipase A2, group VI |
261 |
0.85 |
chr8_58912073_58913264 | 1.30 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
28 |
0.88 |
chr10_79853167_79854282 | 1.30 |
Ptbp1 |
polypyrimidine tract binding protein 1 |
703 |
0.32 |
chr3_132086657_132087690 | 1.30 |
Dkk2 |
dickkopf WNT signaling pathway inhibitor 2 |
1881 |
0.39 |
chr17_17374315_17374537 | 1.29 |
Riok2 |
RIO kinase 2 |
117 |
0.64 |
chr4_124693695_124693906 | 1.29 |
Utp11 |
UTP11 small subunit processome component |
200 |
0.86 |
chr1_135509635_135510447 | 1.29 |
Nav1 |
neuron navigator 1 |
343 |
0.85 |
chr5_26904124_26905425 | 1.29 |
Dpp6 |
dipeptidylpeptidase 6 |
79 |
0.98 |
chr18_79106829_79107281 | 1.28 |
Setbp1 |
SET binding protein 1 |
2336 |
0.42 |
chr12_76533005_76533566 | 1.28 |
Mir5135 |
microRNA 5135 |
73 |
0.52 |
chr5_119803355_119804193 | 1.28 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
3893 |
0.21 |
chr4_116820565_116821781 | 1.28 |
Hpdl |
4-hydroxyphenylpyruvate dioxygenase-like |
534 |
0.58 |
chr7_30788897_30789233 | 1.28 |
Krtdap |
keratinocyte differentiation associated protein |
737 |
0.43 |
chr4_143299758_143300004 | 1.28 |
Pdpn |
podoplanin |
317 |
0.87 |
chr17_46496532_46497753 | 1.28 |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
431 |
0.7 |
chr4_141445411_141445570 | 1.27 |
Zbtb17 |
zinc finger and BTB domain containing 17 |
784 |
0.47 |
chrX_74373312_74373625 | 1.27 |
Slc10a3 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 3 |
119 |
0.65 |
chr14_21052657_21053177 | 1.27 |
Adk |
adenosine kinase |
272 |
0.63 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.9 | 3.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.9 | 2.8 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.9 | 3.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.9 | 2.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.8 | 2.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 2.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.8 | 2.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.7 | 2.2 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.7 | 2.9 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.7 | 2.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.7 | 2.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.7 | 1.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.7 | 2.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.7 | 1.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.7 | 2.7 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.7 | 2.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.7 | 2.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.7 | 5.3 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.7 | 0.7 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.6 | 1.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.6 | 4.9 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.6 | 2.4 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 3.0 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.6 | 1.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.6 | 1.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 1.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.6 | 2.3 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.6 | 2.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 2.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 1.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.6 | 1.7 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 2.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 0.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.5 | 1.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 3.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.5 | 2.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.5 | 2.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 2.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 1.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.5 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.5 | 1.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.5 | 3.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.5 | 1.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.5 | 2.0 | GO:0032898 | neurotrophin production(GO:0032898) |
0.5 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.5 | 1.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.5 | 4.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 2.0 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.5 | 1.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.5 | 0.5 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.5 | 2.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.5 | 2.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.5 | 1.4 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.5 | 0.5 | GO:0015744 | succinate transport(GO:0015744) |
0.5 | 2.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 1.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 3.8 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.5 | 2.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 1.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.5 | 1.4 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 4.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.5 | 2.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.5 | 1.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.5 | 1.4 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.4 | 1.3 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 1.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.4 | 0.9 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 1.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 1.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 0.4 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.4 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 2.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 0.8 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.4 | 1.6 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 1.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 0.4 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.4 | 1.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 2.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.4 | 1.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 0.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.4 | 1.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 1.6 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.4 | 1.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 1.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.9 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 0.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 1.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.4 | 1.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 0.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 1.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 1.9 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.4 | 1.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 0.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 1.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 1.5 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.4 | 1.8 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.4 | 1.8 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 1.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 2.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 1.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.4 | 1.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 2.9 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.4 | 1.1 | GO:0033387 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 1.1 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 1.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 1.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.4 | 0.7 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.4 | 1.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.4 | 1.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 2.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 1.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.4 | 1.4 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.3 | 2.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 3.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 2.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 1.4 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.3 | 1.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 3.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 2.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 1.7 | GO:0060022 | hard palate development(GO:0060022) |
0.3 | 1.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 1.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 0.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.3 | 1.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.7 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 1.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 5.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 1.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 3.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.3 | 0.7 | GO:0043174 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
0.3 | 0.7 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.3 | 1.6 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 3.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 0.6 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 2.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 0.6 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.3 | 1.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 1.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.3 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.6 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 1.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 1.9 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 1.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.3 | 0.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.3 | 2.8 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.3 | 3.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 0.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 0.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 0.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 1.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 0.3 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.3 | 1.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 0.9 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 1.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 0.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.3 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.9 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 1.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 1.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 1.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.3 | 0.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 0.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 3.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 2.0 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.9 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 1.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.3 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 1.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.3 | 0.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 2.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.9 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 2.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 1.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.6 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 0.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.3 | 0.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 1.7 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.3 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 1.4 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 | 1.4 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.3 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 0.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 0.8 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 1.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.8 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 0.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 | 0.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 1.6 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 1.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 2.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.8 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 1.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 0.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.3 | 3.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 2.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 0.3 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 1.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 1.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.3 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.3 | 3.5 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.3 | 0.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 2.0 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.7 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 0.7 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.2 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.2 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 1.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.5 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.2 | 0.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 1.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 1.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 2.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 1.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 2.1 | GO:0000479 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 0.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 1.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.5 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 2.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 2.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 4.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 1.4 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 0.9 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.9 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.7 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 2.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.5 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.9 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.7 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.2 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.2 | GO:1905214 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 1.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 1.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 5.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 1.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 1.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 1.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.4 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.2 | 0.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 0.6 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.9 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 0.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 1.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.6 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.4 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 0.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.8 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.2 | 1.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.8 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 0.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 2.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.4 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.2 | 0.4 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.2 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 1.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.4 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.2 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.2 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.2 | 0.4 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 1.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.6 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 2.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 1.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 1.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.4 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.2 | 0.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 0.2 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.2 | 1.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 2.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.8 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.4 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.2 | 1.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.8 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.6 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 1.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 4.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.8 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 1.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.2 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.8 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.6 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.2 | 0.6 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.2 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.2 | 0.4 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.2 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.9 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.2 | GO:0072367 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 1.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.2 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 1.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.7 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 3.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.2 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.2 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 2.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 7.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.4 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.7 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.2 | 1.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 0.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 1.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 1.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 1.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 1.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 3.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.2 | GO:0090672 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.2 | 0.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.9 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 0.4 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.2 | 0.9 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.4 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.5 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.2 | 0.5 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.7 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.2 | 0.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.2 | 5.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 1.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 1.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 2.4 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.2 | 1.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.7 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 0.5 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.7 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 5.5 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.9 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 1.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.5 | GO:0046959 | habituation(GO:0046959) |
0.2 | 1.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.3 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 1.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.5 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 1.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 1.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.2 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.5 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 0.5 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.0 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.2 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.2 | 3.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.3 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.2 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.8 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.3 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.2 | 2.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 1.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.5 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.5 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.2 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.3 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 1.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 1.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 0.6 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.2 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 0.5 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 3.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.2 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.2 | 0.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.5 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 1.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.2 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 0.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 2.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.8 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 0.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 1.1 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) ribonucleotide catabolic process(GO:0009261) |
0.2 | 5.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 1.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.3 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 0.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.6 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.6 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 1.6 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.6 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 2.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 2.0 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 0.1 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 1.7 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.9 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.1 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.3 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.7 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.8 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 1.2 | GO:0051292 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.1 | 0.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.8 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 2.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.4 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.4 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 1.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.9 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 1.1 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 1.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.3 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0035794 | positive regulation of mitochondrial membrane permeability(GO:0035794) |
0.1 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.3 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.1 | 1.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 2.9 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 1.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 1.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.9 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.4 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.1 | 1.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 2.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.6 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.4 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 0.6 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 2.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 2.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.6 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.2 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.1 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.5 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.1 | 0.2 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 1.0 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.9 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 0.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.1 | 0.7 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 3.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 4.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.7 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.3 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 2.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.9 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 1.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 3.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 1.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 4.7 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 1.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 1.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 5.0 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 2.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 2.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 1.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.7 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.4 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.1 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 1.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 1.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 4.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.7 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 4.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 2.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.3 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.5 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.4 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 2.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.7 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 1.9 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 2.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.4 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.1 | 0.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 1.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.3 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.3 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 1.9 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 2.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.6 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.2 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.5 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.2 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.1 | 0.4 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.8 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 1.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.2 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.1 | 0.2 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.3 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 1.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 4.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 1.3 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:0046755 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 2.9 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 1.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.1 | 1.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 3.3 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.7 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 1.0 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 5.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 1.0 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 3.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 2.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.1 | 2.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.1 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.6 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.1 | 2.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 0.1 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.1 | 0.1 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.1 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 0.1 | GO:0090188 | regulation of pancreatic juice secretion(GO:0090186) negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) |
0.1 | 0.3 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.3 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 1.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.5 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.1 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.1 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 1.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.5 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:0019692 | 2'-deoxyribonucleotide metabolic process(GO:0009394) deoxyribose phosphate metabolic process(GO:0019692) |
0.1 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.2 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.7 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 1.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 0.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.1 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.1 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) |
0.1 | 0.3 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.8 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 1.5 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.0 | 2.1 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.0 | 0.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.0 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.0 | 0.1 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.0 | 0.0 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.0 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.4 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.7 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.0 | 0.2 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.6 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.6 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 1.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.0 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0043366 | beta selection(GO:0043366) |
0.0 | 0.0 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 1.3 | GO:1903747 | regulation of protein targeting to mitochondrion(GO:1903214) regulation of establishment of protein localization to mitochondrion(GO:1903747) |
0.0 | 0.7 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.2 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0044766 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.0 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.0 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.5 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.0 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.2 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.2 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.0 | 0.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.0 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.1 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.0 | 0.0 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0072506 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.0 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.5 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 2.1 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.1 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.7 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.3 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 1.4 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.1 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.3 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.0 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.0 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.3 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.0 | GO:0044321 | response to leptin(GO:0044321) |
0.0 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0045414 | interleukin-8 biosynthetic process(GO:0042228) regulation of interleukin-8 biosynthetic process(GO:0045414) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 1.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 2.4 | GO:0030689 | Noc complex(GO:0030689) |
0.6 | 1.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 1.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 2.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 2.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.5 | 2.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 2.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 1.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 2.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 1.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 2.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 1.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 1.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 1.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 1.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 1.1 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.1 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 1.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 0.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 1.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 1.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 4.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 2.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 2.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 1.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 1.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 0.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 2.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 2.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 1.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 3.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 6.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 3.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 1.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.1 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 2.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 5.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 1.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 2.8 | GO:0032797 | SMN complex(GO:0032797) |
0.3 | 0.3 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.3 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 2.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 1.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 1.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 0.3 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.3 | 2.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 0.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 2.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 3.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 1.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 0.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 2.3 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 1.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 2.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 3.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 1.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 2.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 1.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 2.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.9 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 2.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 1.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 5.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 1.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 3.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 0.8 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 0.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 2.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 1.0 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 2.3 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 1.4 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.8 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 2.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 2.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 7.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.0 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 3.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.8 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 8.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 10.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 1.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 1.5 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 1.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 2.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 1.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 5.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 6.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 9.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.2 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 2.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 7.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 2.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.2 | 9.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 1.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 1.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 1.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.6 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.2 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 2.9 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 3.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 2.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 2.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 2.7 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 1.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 8.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 4.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 2.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.7 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 2.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 1.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 3.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 2.0 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 3.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 2.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 3.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 5.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 3.2 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 5.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.6 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 4.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 3.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 3.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 2.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 4.9 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 2.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.7 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 43.5 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 2.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 2.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 3.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.6 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 1.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 25.1 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 7.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 5.0 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.7 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 5.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 86.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.4 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 6.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 5.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.8 | GO:0030496 | midbody(GO:0030496) |
0.1 | 4.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 2.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 8.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 2.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 2.8 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 1.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 1.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.5 | GO:0005844 | polysome(GO:0005844) |
0.0 | 4.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.8 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 2.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 1.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 3.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.0 | 0.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.6 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 1.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 1.8 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 1.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.0 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 12.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.8 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.4 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 11.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 1.3 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 2.6 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 1.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.0 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.0 | GO:0071437 | invadopodium(GO:0071437) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.9 | 4.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 2.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.7 | 0.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 2.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.6 | 1.9 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 1.9 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.6 | 5.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 3.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 1.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.6 | 2.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.6 | 1.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.5 | 2.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 2.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 2.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 1.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.5 | 2.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 5.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.5 | 2.0 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 2.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 1.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 2.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 2.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 1.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 0.5 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.4 | 2.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 4.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 1.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 2.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 1.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 1.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 0.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 1.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.4 | 1.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 1.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 4.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.4 | 1.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 2.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 1.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 2.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 0.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.4 | 2.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 1.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 1.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 1.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.1 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 1.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 3.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 2.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 2.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 1.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 0.6 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.3 | 1.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 0.3 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.3 | 0.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 1.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 1.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 6.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 1.2 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 1.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 0.9 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 2.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 5.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 1.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 0.8 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.3 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 1.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 2.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.3 | 0.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 2.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 1.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 1.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 4.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 0.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 3.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 1.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 1.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 2.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 1.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 1.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 3.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 1.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 3.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 1.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.2 | 0.2 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 6.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.7 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 4.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 0.9 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 0.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.9 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 2.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.9 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 3.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 0.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) single guanine insertion binding(GO:0032142) |
0.2 | 0.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 2.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 6.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 2.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 4.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 0.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 1.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 1.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 1.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 3.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.8 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 0.8 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 2.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 2.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 1.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 1.0 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 9.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 0.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 1.2 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.4 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 2.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 1.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 2.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 1.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 1.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 3.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.6 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 10.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.2 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.6 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 4.6 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.9 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 6.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 7.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 2.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 3.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 3.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.2 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 2.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 5.0 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 1.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 1.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 4.9 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 2.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 0.8 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 0.9 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 1.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 1.8 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.2 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 1.0 | GO:0018652 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 5.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 1.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 1.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 1.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 2.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 7.5 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 1.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 1.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 3.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 1.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 7.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0019114 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 1.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 2.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 1.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 2.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 2.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 1.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 2.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 21.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.7 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 1.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 3.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 1.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 3.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 1.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 2.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 3.9 | GO:0016853 | isomerase activity(GO:0016853) |
0.1 | 0.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.7 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 2.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 2.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 1.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.8 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 1.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 1.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.0 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 7.5 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.9 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.6 | GO:0043864 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.5 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 3.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.6 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 3.2 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 2.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 4.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 2.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.4 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 2.7 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.9 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 1.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.3 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 2.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 2.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 7.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.1 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 1.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 2.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 2.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 2.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 1.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 0.1 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 1.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 8.4 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 4.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 2.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0034582 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.7 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 1.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 31.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.1 | GO:0048403 | neurotrophin binding(GO:0043121) brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.5 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 1.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 1.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 1.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.2 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 1.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 6.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 2.5 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 2.8 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 1.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 1.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.1 | GO:0034562 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.4 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0034824 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 1.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 1.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.0 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.7 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.0 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.0 | 0.2 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.1 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 2.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.6 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.4 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.2 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 3.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 1.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.2 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 1.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 2.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 3.8 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 6.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 5.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 3.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 3.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 5.0 | PID ATM PATHWAY | ATM pathway |
0.2 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 8.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 7.6 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 0.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 9.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 3.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 5.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 5.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 4.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 4.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.7 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 3.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.2 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 7.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 5.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.4 | 4.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 3.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 0.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 3.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 3.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 8.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 2.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 6.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 5.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 4.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 3.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 2.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 4.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 3.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 3.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 3.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 11.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 2.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 10.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 2.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.9 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 2.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 1.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 5.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 2.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 2.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 1.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 1.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 1.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 3.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 4.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 2.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 1.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.2 | 3.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 3.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 4.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 2.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 9.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 7.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 4.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 5.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 1.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 1.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 6.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 5.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 2.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 1.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 2.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.2 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 1.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 6.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 5.0 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 1.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.6 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.2 | 6.3 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.2 | 4.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 2.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 3.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 2.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 2.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.0 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.6 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 5.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 3.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 2.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 7.9 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 1.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.5 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.6 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.8 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 11.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 5.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 2.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 4.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.7 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 1.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 4.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 1.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.2 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.1 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 3.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |